Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Some women taking part in RECOVER research were more likely to experience Long COVID compared to men.
During the February 13th RECOVER Research Review (R3) Seminar, several pathobiology study awardees presented about the mechanisms of neurological (brain and nervous system) symptoms of Long COVID.
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
During the January 23rd RECOVER Research Review (R3) Seminar, researchers presented on the progress and future directions of the RECOVER Initiative. Speakers from the RECOVER adult, pediatric, and autopsy cohorts provided an overview of the progress to date, what is in the pipeline and the ultimate promise of RECOVER for each of the cohorts. A review of the current state of the science of Long COVID and gaps in knowledge was also discussed.
During the December 12th RECOVER Research Review (R3) Seminar, panelists discussed immune features of Long COVID, the relationship between Long COVID and metabolism (chemical reactions that provide the body with energy), and impact of acute and Long COVID on the brain.
During the November 14th RECOVER Research Review (R3) Seminar, researchers discussed multiple different biological mechanisms likely underlaid PASC manifestations. This seminar explored several prominent mechanisms that were areas of active study, including persistent SARS-CoV-2 viral reservoirs, abnormal immune system activation, and effects on metabolic pathways.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.